SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 26, 2001
--------------
SAFEGUARD SCIENTIFICS, INC.
----------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
PENNSYLVANIA 1-5620 23-1609753
- -----------------------------------------------------------------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
800 The Safeguard Building 435 Devon Park Drive, Wayne, PA 19087
- --------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (610) 293-0600
--------------
Item 5. Other Events.
Registrant is filing (i) as Exhibit 99 hereto its Selected Consolidated
Financial Data, Management's Discussion and Analysis of Financial Condition, and
Registrant's consolidated financial statements and (ii) as Exhibit 23, a consent
of KPMG LLP, Independent auditors
Item 7. Financial Statements and Exhibits.
(c). Exhibits
23 Consent of KPMG LLP, Independent Auditors
99.1 Selected Consolidated Financial Data, Management's
Discussion and Analysis of Financial Condition
99.2 Consolidated Financial Statements
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Safeguard Scientifics, Inc.
Date: March 26, 2001 By: /s/ Gerald A. Blitstein
-----------------------
Gerald A. Blitstein
Executive Vice President and
Chief Financial Officer